| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVDX | Common Stock | Sale | $63,742 | -7,427 | -2% | $8.58 | 369,603 | 16 Oct 2024 | Direct | F1, F2 |
| transaction | AVDX | Common Stock | Options Exercise | $6,994 | +2,172 | +0.59% | $3.22 | 371,775 | 17 Oct 2024 | Direct | |
| transaction | AVDX | Common Stock | Options Exercise | $18,135 | +5,632 | +1.5% | $3.22 | 377,407 | 17 Oct 2024 | Direct | |
| transaction | AVDX | Common Stock | Options Exercise | $46,238 | +12,200 | +3.2% | $3.79 | 389,607 | 17 Oct 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVDX | Employee Stock Option (right to buy) | Options Exercise | $0 | -2,172 | -100% | $0.000000 | 0 | 17 Oct 2024 | Common Stock | 2,172 | $3.22 | Direct | F3 |
| transaction | AVDX | Employee Stock Option (right to buy) | Options Exercise | $0 | -5,632 | -100% | $0.000000 | 0 | 17 Oct 2024 | Common Stock | 5,632 | $3.22 | Direct | F4 |
| transaction | AVDX | Employee Stock Option (right to buy) | Options Exercise | $0 | -12,200 | -40% | $0.000000 | 18,640 | 17 Oct 2024 | Common Stock | 12,200 | $3.79 | Direct | F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $8.58 to $8.595. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | The option vested 25% on the first anniversary of the grant date and monthly thereafter over 36 months. The grant date was December 6, 2017. |
| F4 | The option vested 25% on the first anniversary of the grant date and monthly thereafter over 36 months. The grant date was March 5, 2018. |
| F5 | The option vested 25% on the first anniversary of the grant date and monthly thereafter over 36 months. The grant date was March 20, 2019. |
General Counsel and Secretary, Senior Vice President